Key result
Review categorizes hypercholesterolemia drugs as inhibitors or inducers of CYP enzymes and key transporters.
Early identification and treatment of dyslipidemia are emphasized by multisociety guidelines to reduce the lifetime risk of ASCVD and death.
Answers are grounded in this paper and cite their sources.
Supports early dyslipidemia intervention in practice; leaves open optimal thresholds and implementation research.
Recently published multisociety guidelines for the management of dyslipidemia emphasize early identification and treatment of dyslipidemia to reduce the lifetime risk of atherosclerotic cardiovascular disease (ASCVD) and death.
No takes yet. Share an insight, caveat, or question.
A 2026 study reported a review.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: